Melinda Lackey

2023

In 2023, Melinda Lackey earned a total compensation of $701.7K as SVP, Legal & Administration at ZIOPHARM Oncology, a 8% decrease compared to previous year.

Compensation breakdown

Option Awards$76,620
Salary$312,084
Other$313,033
Total$701,737

Lackey received $313K in other compensation, accounting for 45% of the total pay in 2023.

Lackey also received $76.6K in option awards and $312.1K in salary.

Rankings

In 2023, Melinda Lackey's compensation ranked 1,555th out of 2,773 executives tracked by ExecPay. In other words, Lackey earned more than 43.9% of executives.

ClassificationRankingPercentile
All
1,555
out of 2,773
44th
Division
Manufacturing
917
out of 1,516
40th
Major group
Chemicals And Allied Products
588
out of 855
31st
Industry group
Drugs
572
out of 821
30th
Industry
Pharmaceutical Preparations
403
out of 590
32nd
Source: SEC filing on April 26, 2024.

Lackey's colleagues

We found two more compensation records of executives who worked with Melinda Lackey at ZIOPHARM Oncology in 2023.

2023

Kevin Boyle

ZIOPHARM Oncology

Chief Executive Officer

2023

Drew Deniger

ZIOPHARM Oncology

VP, Research and Development

News

You may also like